Literature DB >> 29420276

Enhancing responses to cancer immunotherapy.

Pia Kvistborg1, Jonathan W Yewdell2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29420276     DOI： 10.1126/science.aar6574

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  10 in total

1.  The Human Immunopeptidome Project: A Roadmap to Predict and Treat Immune Diseases.

Authors:  Juan Antonio Vizcaíno; Peter Kubiniok; Kevin A Kovalchik; Qing Ma; Jérôme D Duquette; Ian Mongrain; Eric W Deutsch; Bjoern Peters; Alessandro Sette; Isabelle Sirois; Etienne Caron
Journal:  Mol Cell Proteomics       Date:  2019-11-19       Impact factor: 5.911

2.  Pinpointing the tumor-specific T cells via TCR clusters.

Authors:  Mikhail M Goncharov; Ekaterina A Bryushkova; Nikita I Sharaev; Valeria D Skatova; Anastasiya M Baryshnikova; George V Sharonov; Vadim Karnaukhov; Maria T Vakhitova; Igor V Samoylenko; Lev V Demidov; Sergey Lukyanov; Dmitriy M Chudakov; Ekaterina O Serebrovskaya
Journal:  Elife       Date:  2022-04-04       Impact factor: 8.713

Review 3.  Immunomodulating Nanomedicine for Cancer Therapy.

Authors:  Zhigang Liu; Wen Jiang; Jutaek Nam; James J Moon; Betty Y S Kim
Journal:  Nano Lett       Date:  2018-09-10       Impact factor: 11.189

4.  A cell-engineered system to assess tumor cell sensitivity to CD8+ T cell-mediated cytotoxicity.

Authors:  Nadine Nelson; Marta Lopez-Pelaez; Asis Palazon; Edmund Poon; Maike De La Roche; Simon Barry; Viia Valge-Archer; Robert W Wilkinson; Simon J Dovedi; Paul D Smith
Journal:  Oncoimmunology       Date:  2019-04-26       Impact factor: 8.110

5.  Loss of natural resistance to schistosome in T cell deficient rat.

Authors:  Liaoxun Lu; Junjian Hu; Tianzhu Chao; Zhijun Chen; Zhuangzhuang Liu; Xinsong Luo; Yinming Liang; Pei He; Lichen Zhang
Journal:  PLoS Negl Trop Dis       Date:  2020-12-21

6.  Proteogenomic discovery of neoantigens facilitates personalized multi-antigen targeted T cell immunotherapy for brain tumors.

Authors:  Samuel Rivero-Hinojosa; Melanie Grant; Aswini Panigrahi; Huizhen Zhang; Veronika Caisova; Catherine M Bollard; Brian R Rood
Journal:  Nat Commun       Date:  2021-11-18       Impact factor: 14.919

Review 7.  Vaccines for Non-Viral Cancer Prevention.

Authors:  Cristina Bayó; Gerhard Jung; Marta Español-Rego; Francesc Balaguer; Daniel Benitez-Ribas
Journal:  Int J Mol Sci       Date:  2021-10-09       Impact factor: 5.923

Review 8.  Selecting the optimal immunotherapy regimen in driver-negative metastatic NSCLC.

Authors:  Michael J Grant; Roy S Herbst; Sarah B Goldberg
Journal:  Nat Rev Clin Oncol       Date:  2021-06-24       Impact factor: 66.675

Review 9.  Reconstructing the tumor architecture into organoids.

Authors:  Zhimin Luo; Xingwu Zhou; Kalpana Mandal; Na He; Wally Wennerberg; Moyuan Qu; Xing Jiang; Wujin Sun; Ali Khademhosseini
Journal:  Adv Drug Deliv Rev       Date:  2021-06-19       Impact factor: 17.873

Review 10.  Exploiting Tumor Neoantigens to Target Cancer Evolution: Current Challenges and Promising Therapeutic Approaches.

Authors:  Ravi G Gupta; Fenge Li; Jason Roszik; Gregory Lizée
Journal:  Cancer Discov       Date:  2021-03-15       Impact factor: 38.272
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.